ONCOTYPE MAP PAN-CANCER TISSUE

The mark consists of the stylized mark ONCOTYPE MAP PAN-CANCER TISSUE, with "MAP" in a larger font. The words "PAN-CANCER TISSUE" are stacked below "ONCOTYPE MAP".

Mark For: ONCOTYPE MAP PAN-CANCER TISSUE® trademark registration is intended to cover the categories of laboratory research in the field of the field of cancer research and disease classification; Providing laboratory research services in the field of genetic testing, including next-generation sequencing (NGS), namely, cancer biology. [all]

Status

2020-09-01 UTC
⟳ Refresh

LIVE APPLICATION Awaiting Examination

Research	OneLook Acronym Finder
Serial Number	90142985
Registration Number	6570603
Mark Literal Elements	ONCOTYPE MAP PAN-CANCER TISSUE
Mark Drawing Type	-
Mark Type	SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	NEW APPLICATION PROCESSING 2020-08-31
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	042 - Primary Class (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Sana Hakim
Attorney Docket Number	2862081-201

Timeline

IC 042. US 100 101. G & S: Laboratory research in the field of the field of cancer research and disease classification; Providing laboratory research services in the field of genetic testing, including next-generation sequencing (NGS), namely, cancer biology
IC 044. US 100 101. G & S: Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals, namely oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer